Development of Bortezomib Induced Peripheral Neuropathy (BiPN) In Multiple Myeloma: Incidence and Molecular Characterization In Newly Diagnosed Patients Treated with Bortezomib

被引：0
|
作者：
Broyl, Annemiek [1 ]
Corthals, Sophie [1 ]
Jongen, Joost L. M. [1 ]
van der Holt, Bronno [1 ]
Kuiper, Rowan [1 ]
de Knegt, Yvonne [1 ]
el Jarari, Laila [1 ]
Bertsch, Uta [2 ]
Lokhorst, Henk [3 ]
Durie, Brian G. M. [4 ]
Goldschmidt, Hartmut [2 ]
Sonneveld, Pieter [5 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
[2] Univ Klinikum, Med Klin 5, Heidelberg, Germany
[3] Univ Med Ctr, Utrecht, Netherlands
[4] Aptium Oncol Inc, Rsch Network, Los Angeles, CA USA
[5] Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [31] Peripheral neuropathy in newly diagnosed multiple myeloma patients
    Ballegaard, Martin
    Gimsing, Peter
    NEUROLOGY, 2008, 70 (11) : A366 - A367
  • [32] Bortezomib-induced painful neuropathy in patients with multiple myeloma
    Bilinska, Malgorzata
    Usnarska-Zubkiewicz, Lidia
    Pokryszko-Dragan, Anna
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (05): : 421 - 426
  • [33] COMPARISON OF FOUR NEUROPATHY ASSESSMENT SCALES IN EVALUATION OF TREATMENT EMERGENT NEUROPATHY IN NEWLY DIAGNOSED PATIENTS OF MULTIPLE MYELOMA TREATED WITH BORTEZOMIB BASED REGIMEN
    Lakshman, A.
    Prakash, G.
    Modi, M.
    Malhotra, P.
    Nampoothiri, R.
    Khadwal, A.
    Suri, V.
    Jain, S.
    Kumari, S.
    Varma, N.
    Varma, S.
    HAEMATOLOGICA, 2016, 101 : 533 - 533
  • [34] Long-term Reversibility Analysis of Peripheral Neuropathy in Multiple Myeloma Patients Treated with Bortezomib
    Garcia Guinon, Antonio
    Escoda, Lourdes
    Ben, Randa
    Vicent, Ana
    Rivero, Eugenia
    Alex, Martinez
    Campoy, Desiree
    Abella, Eugenia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E123 - E124
  • [35] Bortezomib, lenalidomide, and dexamethasone versus bortezomib, doxorubicin, and dexamethasone in newly diagnosed multiple myeloma
    Liang, Dong
    Bai, Shenrui
    Feng, Demei
    Chen, Guanjun
    Liang, Yang
    Wang, Hua
    BMC CANCER, 2024, 24 (01)
  • [36] Assessment of bortezomib induced peripheral neuropathy in multiple myeloma by the reduced Total Neuropathy Score
    Zaroulis, Chrysothea K.
    Chairopoulos, Konstantinos
    Sachanas, Sotirios P.
    Maltezas, Dimitris
    Tzenou, Tatiana
    Pessach, Ilias
    Koulieris, Efstathios
    Koutra, Eleni
    Kilindireas, Konstantinos
    Pangalis, Gerasimos A.
    Kyrtsonis, Marie-Christine
    LEUKEMIA & LYMPHOMA, 2014, 55 (10) : 2277 - 2283
  • [37] INCIDENCE OF NEUROPATHY IN PATIENTS TREATED WITH SUBCUTANEOUS BORTEZOMIB
    Vicent Castello, A.
    Pellise Guinjoan, A.
    Escoda Teigell, L.
    Casanova Molla, J.
    Pascual Rubio, V
    Talarn Forcadell, C.
    Do Nascimento, J.
    Vallansot, R.
    Aguinaco Culebras, R.
    Gimenez Perez, T.
    Araguas Arasanz, C.
    Bru Orobal, N.
    Esteban Figuerola, A.
    Sarra Escarre, J.
    HAEMATOLOGICA, 2015, 100 : 113 - 114
  • [38] A Comparison of Cyclophosphamide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma
    Figueiredo, Amarilis
    Atkins, Harold
    Mallick, Ranjeeta
    Kekre, Natasha
    Kew, Andrea
    McCurdy, Arleigh
    BLOOD, 2016, 128 (22)
  • [39] Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature
    Argyriou, Andreas A.
    Iconomou, Gregoris
    Kalofonos, Haralabos P.
    BLOOD, 2008, 112 (05) : 1593 - 1599
  • [40] Impact of dose modification on intravenous Bortezomib-induced peripheral neuropathy in multiple myeloma patients
    Cho, Juhee
    Kang, Danbee
    Lee, Ji Yean
    Kim, Kihyun
    Kim, Seok Jin
    SUPPORTIVE CARE IN CANCER, 2014, 22 (10) : 2669 - 2675
12345